[11 C]Methionine emerges as a new biomarker for tracking active myeloma lesions-Reference-Cited by-同舟云学术

[11 C]Methionine emerges as a new biomarker for tracking active myeloma lesions

Published:2017-05-03 Issue:5 Volume:181 Page:701-703
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Lapa Constantin¹^ORCID,Schreder Martin²,Lückerath Katharina¹,Samnick Samuel¹,Rudelius Martina³⁴⁵,Buck Andreas K.¹,Kortüm Klaus M.²,Einsele Hermann²,Rosenwald Andreas³⁴,Knop Stefan²

Affiliation:

1. Department of Nuclear Medicine; University Hospital Würzburg; Würzburg Germany

2. Department of Haematology and Oncology; University Hospital Würzburg; Würzburg Germany

3. Institute of Pathology; University of Würzburg; Würzburg Germany

4. Comprehensive Cancer Centre Mainfranken; Würzburg Germany

5. Institute of Pathology; University of Duesseldorf; Duesseldorf Germany

Funder

Wilhelm Sander-Stiftung

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14696/fullpdf

Reference10 articles.

1. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma;Bartel;Blood,2009

2. Multiple myeloma: molecular imaging with 11C-Methionine PET/CT-initial experience;Dankerl;Radiology,2007

3. Whole-body (18)F-FDG PET identifies high-risk myeloma;Durie;Journal of Nuclear Medicine,2002

4. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma;Kumar;Lancet Oncol,2016

5. 11C-Methionine-PET in multiple myeloma: correlation with clinical parameters and bone marrow involvement;Lapa;Theranostics,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18F-Fluciclovine PET/CT;Clinical Nuclear Medicine;2022-05-12

2. Molecular Imaging in Multiple Myeloma—Novel PET Radiotracers Improve Patient Management and Guide Therapy;Frontiers in Nuclear Medicine;2022-02-25

3. Association of minimal residual disease levels with clinical outcomes in patients with mantle cell lymphoma: A meta-analysis;Leukemia Research;2021-09

4. Diagnostic role of 11C-methionine PET/CT in patients with multiple myeloma and other plasma cell malignancy: a literature review;Clinical and Translational Imaging;2021-01-05

5. Incidental Finding of an Ovarian Carcinoid on 11C-Methionine PET/CT;Clinical Nuclear Medicine;2020-07-22